| Name | Clobetasone 17-Butyrate |
|---|---|
| Synonyms |
21-Chloro-9-fluoro-16β-methyl-17-(1-oxobutoxy)pregna-1,4-diene-3,11,20-trione
Kindavate (16β)-21-chloro-9-fluoro-16-methyl-3,11,20-trioxopregna-1,4-dien-17-yl butanoate molivate H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione|(Deflazacort Impurity) EINECS 246-635-9 Hydroxy Stanozolol butyric acid [(8S,9R,10S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-3,11-diketo-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] ester [(8S,9R,10S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-10,13,16-trimethyl-3,11-dioxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] butanoate Bichlorobetasone butyrate )-3,17-Dihydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl|piperidinium Bromide CCl Clobetasone butyrate, 10 mM in DMSO 21-Chloro-9-fluoro-17-hydroxy-16b-methylpregna-1,4-diene-3,11,20-trione 17-butyrate 21-Chloro-9-fluoro-17-hydroxy-16-methylpregna-1,4-diene-3,11,20-trione 17-butyrate MFCD00133196 11,20-trione,21-chloro-9-fluoro-17-hydroxy-16-beta-methyl-pregna-4-diene-3 )-11-Hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-pregna-1,4-diene-3,20-dione [(8S,9R,10S,13S,14S,16S,17R)-17-(2-chloroethanoyl)-9-fluoro-10,13,16-trimethyl-3,11-dioxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] butanoate 21-chloro-9-fluoro-17-hydroxy-16-beta-methylpregna-1,4-diene,3,11,20-trione Pregna-1,4-diene-3,11,20-trione, 21-chloro-9-fluoro-16-methyl-17-(1-oxobutoxy)-, (16β) )-16-Methyl-17,20:20,21-bis[methylenebis(oxy)]-pregna-1,4-diene-3,11-dione )-6-Bromo-9-fluoro-11,17-dihydroxy-16-methyl-21-[(1-oxopentyl)oxy]-pregna-1,4-diene-3,20-dione Pregna-1,4-diene-3,11,20-trione, 21-chloro-9-fluoro-17-hydroxy-16β-methyl-, butyrate (8CI) Clobetasone butyrate solution in Acetonitrile,100μg/mL Clobetasone butyrate for system suitability CRS )-pregn-5-en-20-one Butanoic acid, (16β)-21-chloro-9-fluoro-16-methyl-3,11,20-trioxopregna-1,4-dien-17-yl ester pregna-1,4-diene-3,11,20-trione,21-chloro-9-fluoro-16-methyl-17-(1-oxobutoxy )-9-Fluoro-11,17,21-trihydroxy-16-methylpregn-4-ene-3,20-dione Clobetasone ButyrateQ: What is Clobetasone Butyrate Q: What is the CAS Number of Clobetasone Butyrate Q: What is the storage condition of Clobetasone Butyrate 20R)-9-Fluoro-11,20-dihydroxy-16-methyl-3-oxopregna-1,4-dien-21-oic Acid|(Betamethasone Impurity) Simvastatin Impurity 44 (16β)-21-Chloro-9-fluoro-16-methyl-3,11,20-trioxopregna-1,4-dien-17-yl butyrate 21-chloro-9-fluoro-16β-methyl-3,11,20-trioxopregna-1,4-dien-17-ylbutanoate Hydroxymestanolone )-16-Methyl-17,21-bis(1-oxopropoxy)pregna-1,4,9-triene-3,20-dione Butyric acid, ester with 21-chloro-9-fluoro-17-hydroxy-16β-methylpregna-1,4-diene-3,11,20-trione (8CI) 3,17-Dihydroxy-16-methyl-(3&beta 21-Chloro-9-fluoro-17-hydroxy-16β-methylpregna-1,4-diene-3,11,20-trione=butyrate 21-Chloro-9-fluoro-17-hydroxy-16b-methylpregna-1,4-diene-3,11,20-trione 17-Butyrate H-Pregna-1,4-dieno[17,16-d]oxazole-3,11,20-trione eumovate (16-beta)-) Betamethasone Butyrate/Clobetamethasone Butyrate )-3-(Acetyloxy)-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide Hydroxytestosterone )-17,21-Bis(acetyloxy)-16-methyl-pregna-1,4,9-triene-3,20-dione Emovate CLOBETASOLE BUTYRATE )-17-Acetyloxy-3-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide Hydroxy-17-i-norethisterone 21-chloro-9-fluoro-17-hydroxy-16beta-methylpregna-1,4-diene-3,11,20-trione 17-butyrate Clobetasone-17-butyrate 4-(methylamino)-3-nitro 17-Butyrate Clonazam impurity B CRS Clobetasone butyrate CRS ClobetasolPropionate-Bp )-3-(Acetyloxy)-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide-d3 sn203 |
| Description | Clobetasone butyrate is a synthetic glucocorticoid and has topical anti-inflammatory activity especially in skin. Clobetasone butyrate can be used to relieve corticosteroid-responsive dermatoses, including atopic dermatitis and psoriasis[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: glucocorticoid[1] |
| In Vivo | Clobetasone butyrate (application on the skin; 0.05%; 7 weeks) induces epidermal thinning in skin, Clobetasone butyrate 7 weeks causes much less epidermal thinning in the pig than flurandrenolone (0.05%) or fluocinolone acetonide (0.025%), both of which causes severe atrophy[1]. Animal Model: Large white domestic pig[1] Dosage: 0.5% application on the skin Administration: 7 weeks Result: Caused moderate to slight atrophy. |
| References |
[2]. Michael Stewart, et al. Clobetasone butyrate for inflammatory skin conditions. |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 573.3±50.0 °C at 760 mmHg |
| Melting Point | 179 °C |
| Molecular Formula | C26H32ClFO5 |
| Molecular Weight | 478.981 |
| Flash Point | 181.1±19.3 °C |
| Exact Mass | 478.192230 |
| PSA | 77.51000 |
| LogP | 4.82 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.551 |
| Stability | Stable. Combustible. Incompatible with strong oxidizing agents. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H351 |
| Precautionary Statements | P281 |
| Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | Xn:Harmful |
| Risk Phrases | R40 |
| Safety Phrases | S22-S36 |
| RIDADR | NONH for all modes of transport |
| RTECS | TU4154083 |